[1]
|
Kaur, K., Gill, J.S., Bansal, P.K., et al. (2017) Neuroinflammation—A Major Cause for Striatal Dopaminergic Degenera-tion in Parkinson’s Disease. Journal of the Neurological Sciences, 381, 308-314.
https://doi.org/10.1016/j.jns.2017.08.3251
|
[2]
|
GBD 2015 Neurological Disorders Collaborator Group (2017) Global, Regional, and National Burden of Neurological Disorders during 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. Lancet Neurology, 11, 877-897. https://doi.org/10.1097/01.ogx.0000511935.64476.66
|
[3]
|
张硕, 高健, 姜立刚. 帕金森病患病率及相关因素的流行病学研究现状[J]. 吉林医药学院学报, 2021, 42(6): 437-439.
|
[4]
|
Yin, L., Xie, Y.Y., Yin, S.Y., et al. (2015) The S-Nitrosylation Status of PCNA Localized in Cytosol Impacts the Apoptotic Pathway in a Parkinson’s Disease Par-adigm. PLOS ONE, 2, e0117546.
https://doi.org/10.1371/journal.pone.0117546
|
[5]
|
Antony, P.M.A., Boyd, O., Trefois, C., et al. (2015) Platelet Mitochondrial Membrane Potential in Parkinson’s Disease. Annals of Clinical and Translational Neurology, 2, 67-73. https://doi.org/10.1002/acn3.151
|
[6]
|
岑川, 何建成. 中医药防治帕金森病药物左旋多巴副作用研究进展[J]. 中华中医药学刊, 2009, 27(12): 2530-2532.
|
[7]
|
Bove, F., Angeloni, B., Sanginario, P., et al. (2023) Neuroplasticity in Levodopa-Induced Dyskinesias: An Overview on Pathophysiology and Therapeutic Targets. Progress in Neurobiology, 232, Article ID: 102548.
https://doi.org/10.1016/j.pneurobio.2023.102548
|
[8]
|
Tian, T., Sun, Y., Wu, H., et al. (2016) Acupuncture Pro-motes MTOR-Independent Autophagic Clearance of Aggregation-Prone Proteins in Mouse Brain. Scientific Reports, 6, Article No. 19714. https://doi.org/10.1038/srep19714
|
[9]
|
Kwon, M., Cheong, M.J., Leem, J.T. and Kim, T.H.. (2021) Effect of Acupuncture on Movement Function in Patients with Parkinson’s Disease: Network Meta-Analysis of Randomized Controlled Trials. Healthcare, 9, Article 1502.
https://doi.org/10.3390/healthcare9111502
|
[10]
|
Pereira, C.R., Criado, M.B., Machado, J., et al. (2021) Acute Ef-fects of Acupuncture in Balance and Gait of Parkinson Disease Patients—A Preliminary Study. Complementary Thera-pies in Clinical Practice, 45, Article ID: 101479.
https://doi.org/10.1016/j.ctcp.2021.101479
|
[11]
|
Moon, S., Sarmento, C.V.M., Colgrove, Y. and Liu, W. (2021) Complementary Health Approaches for People with Parkinson Disease. Archives of Physical Medicine and Rehabilitation, 101, 1475-1477.
https://doi.org/10.1016/j.apmr.2020.03.024
|
[12]
|
Li, K., Xu, S., Wang, R., et al. (2023) Electroacupuncture for Mo-tor Dysfunction and Constipation in Patients with Parkinson’s Disease: A Randomised Controlled Multi-Centre Trial. EClinicalMedicine, 56, Article ID: 101814.
https://doi.org/10.1016/j.eclinm.2022.101814
|
[13]
|
Ning, B., Wang, Z., Wu, Q., et al. (2023) Acupuncture Inhibits Autophagy and Repairs Synapses by Activating the MTOR Pathway in Parkinson’s Disease Depression Model Rats. Brain Research, 1808, Article ID: 148320.
https://doi.org/10.1016/j.brainres.2023.148320
|
[14]
|
Yeo, S. and Lim, S. (2019) Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model. The American Journal of Chinese Medicine, 47, 527-539.
https://doi.org/10.1142/S0192415X19500277
|
[15]
|
Khalil, W.K.B., Assaf, N., ElShebiney, S.A. and Salem, N.A. (2015) Neuroprotective Effects of Bee Venom Acupuncture Therapy against Rotenone-Induced Oxidative Stress and Apoptosis. Neurochemistry International, 80, 79-86.
https://doi.org/10.1016/j.neuint.2014.11.008
|
[16]
|
Sun, M., Wang, M., Yu, Y., et al. (2016) Electroacupuncture Al-leviates Depressive-Like Symptoms and Modulates BDNF Signaling in 6-Hydroxydopamine Rats. Evidence-Based Complementary and Alternative Medicine, 2016, Article ID: 7842362. https://doi.org/10.1155/2016/7842362
|
[17]
|
Pak, M.E., Ahn, S.M., Jung, D.H., et al. (2020) Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neu-rotrophic Factor in a Mouse Model of Parkinson’s Disease. The Journals of Gerontology: Series A, 75, 712-721. https://doi.org/10.1093/gerona/glz256
|
[18]
|
Kim, S.N., Doo, A.R., Park, J.Y., et al. (2011) Acupuncture Enhances the Synaptic Dopamine Availability to Improve Motor Function in a Mouse Model of Parkinson’s Disease. PLOS ONE, 11, e27566.
https://doi.org/10.1371/journal.pone.0027566
|
[19]
|
Yu, J., Min, D., Bai, Y., et al. (2020) Electroacupuncture Alle-viates Parkinson Disease and Regulates the Expression of Brain-Gut Peptides. Experimental Animals, 69, 448-460. https://doi.org/10.1538/expanim.19-0153
|
[20]
|
Kim, S.N., Doo, A.R., Park, J.Y., et al. (2014) Combined Treatment with Acupuncture Reduces Effective Dose and Alleviates Adverse Effect of L-Dopa by Normalizing Parkinson’s Dis-ease-Induced Neurochemical Imbalance. Brain Research, 1544, 33-44. https://doi.org/10.1016/j.brainres.2013.11.028
|
[21]
|
Shintani, T. and Klionsky, D.J. (2004) Autophagy in Health and Disease: A Double-Edged Sword. Science, 306, 990-995. https://doi.org/10.1126/science.1099993
|
[22]
|
Ye, H., Robak, L.A., Yu, M., et al. (2023) Genetics and Pathogenesis of Parkinson’s Syndrome. Annual Review of Pathology: Mechanisms of Disease, 18, 95-121. https://doi.org/10.1146/annurev-pathmechdis-031521-034145
|
[23]
|
Nemade, D., Subramanian, T. and Shivkumar, V. (2021) An Update on Medical and Surgical Treatments of Parkinson’s Disease. Aging and Disease, 12, 1021-1035. https://doi.org/10.14336/AD.2020.1225
|
[24]
|
Park, H. and Poo, M.M. (2013) Neurotrophin Regulation of Neural Circuit Development and Function. Nature Reviews Neuroscience, 14, 7-23. https://doi.org/10.1038/nrn3379
|
[25]
|
Lu, B. (2003) BDNF and Activity-Dependent Synaptic Modulation. Learning & Memory, 10, 86-98.
https://doi.org/10.1101/lm.54603
|
[26]
|
Autry, A.E. and Monteggia, L.M. (2012) Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders. Pharmacological Reviews, 64, 238-258. https://doi.org/10.1124/pr.111.005108
|
[27]
|
Miao, C., Li, X. and Zhang, Y. (2023) Effect of Acupuncture on BDNF Signaling Pathways in Several Nervous System Diseases. Frontiers in Neurology, 14, Article 1248348. https://doi.org/10.3389/fneur.2023.1248348
|
[28]
|
杜靖, 孙作厘, 贾军, 等. 高频电针刺激对帕金森病模型大鼠脑组织中γ-氨基丁酸含量的调节作用[J]. 生理学, 2011, 63(4): 305-310.
|
[29]
|
王述菊, 马骏, 王彦春, 等. 电针对帕金森病模型大鼠黑质区C-Jun氨基末端激酶和TNF-α、IFN-γ、IL-1β蛋白表达的影响[J]. 中华中医药学刊, 2017, 35(1): 43-46.
|
[30]
|
Bruno, F., Abondio, P., Montesanto, A., et al. (2023) The Nerve Growth Factor Receptor (NGFR/P75(NTR)): A Major Player in Alzheimer’s Disease. International Journal of Molecular Sciences, 24, Article 3200.
https://doi.org/10.20944/preprints202301.0239.v1
|
[31]
|
Bruno, F., Malvaso, A., Canterini, S. and Bruni, A.C. (2022) Antimicrobial Peptides (AMPs) in the Pathogenesis of Alzheimer’s Disease: Implications for Diagnosis and Treatment. Antibiotics, 11, Article 726.
https://doi.org/10.20944/preprints202205.0166.v1
|
[32]
|
Shu, Y.H., Lu, X.M., Wei, J.X., et al. (2015) Update on the Role of P75NTR in Neurological Disorders: A Novel Therapeutic Target. Biomedicine & Pharmacotherapy, 76, 17-23. https://doi.org/10.1016/j.biopha.2015.10.010
|
[33]
|
Ibáñez, C.F. and Simi, A. (2012) P75 Neurotrophin Receptor Signaling in Nervous System Injury and Degeneration: Paradox and Opportunity. Trends in Neurosciences, 35, 431-440. https://doi.org/10.1016/j.tins.2012.03.007
|
[34]
|
Wang, Q., Wang, H., Meng, W., et al. (2023) The NONRATT023402.2/Rno-MiR-3065-5p/NGFR Axis Affects Levodopa-Induced Dyskinesia in a Rat Model of Parkin-son’s Disease. Cell Death Discovery, 9, Article No. 342.
https://doi.org/10.1038/s41420-023-01644-2
|
[35]
|
Signorile, A., Ferretta, A., Pacelli, C., et al. (2023) Resveratrol Treatment in Human Parkin-Mutant Fibroblasts Modulates CAMP and Calcium Homeostasis Regulating the Expression of Mitochondria-Associated Membranes Resident Proteins. Biomolecules, 11, Article 1511.
|
[36]
|
Li, J., Li, Q., Xie, C., et al. (2004) β-Actin Is Required for Mitochondria Clustering and ROS Generation in TNF-Induced, Caspase-Independent Cell Death. Journal of Cell Science, 117, 4673-4680.
https://doi.org/10.1242/jcs.01339
|
[37]
|
Hartmann, A., Hunot, S., Michel, P.P., et al. (2000) Caspase-3: A Vulnera-bility Factor and Final Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson’s Disease. Proceedings of the National Academy of Sciences of the United States of America, 6, 2875-2880. https://doi.org/10.1073/pnas.040556597
|
[38]
|
Viswanath, V., Wu, Y., Boonplueang, R., et al. (2001) Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson’s Disease. Journal of Neuroscience, 21, 9519-9528. https://doi.org/10.1523/JNEUROSCI.21-24-09519.2001
|
[39]
|
姜勇. MAPK信号转导通路对炎症反应的调控[J]. 生理学报, 2000, 52(4): 267-271, 280.
|
[40]
|
Xia, X., Harding, T., Weller, M., et al. (2001) Gene Transfer of the JNK Interacting Protein-1 Protects Dopaminergic Neurons in the MPTP Model of Parkinson’s Disease. Proceedings of the National Academy of Sciences of the United States of America, 98, 10433-10438. https://doi.org/10.1073/pnas.181182298
|
[41]
|
Wang, W., Ma, C., Mao, Z. and Li, M. (2004) JNK Inhibition as a Potential Strategy in Treating Parkinson’s Disease. Drug News & Perspectives, 17, 646-654. https://doi.org/10.1358/dnp.2004.17.10.873916
|
[42]
|
张万萍, 余永游. 单胺氧化酶抑制药物神经保护作用的研究进展[J]. 山东化工, 2015, 44(1): 62-64.
|
[43]
|
Finberg, J.P.M. (2019) Inhibitors of MAO-B and COMT: Their Ef-fects on Brain Dopamine Levels and Uses in Parkinson’s Disease. Journal of Neural Transmission, 126, 433-448. https://doi.org/10.1007/s00702-018-1952-7
|